$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000094480919000080 Filed on November 05, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$224.3M	$228.8M	$249.8M
YoY Change	1.12%	-8.42%	1.53%
Cost Of Revenue	$142.3M	$141.9M	$151.0M
YoY Change	-4.82%	-6.03%	11.68%
Gross Profit	$82.10M	$86.90M	$98.90M
YoY Change	13.55%	-12.13%	-10.77%
Gross Profit Margin	36.6%	37.99%	39.59%
Selling, General & Admin	$79.10M	$80.54M	$84.07M
YoY Change	-12.31%	-4.2%	-18.52%
% of Gross Profit	96.35%	92.68%	85.01%
Research & Development	$23.00M	$30.02M	$30.16M
YoY Change	-30.93%	-0.47%	-7.22%
% of Gross Profit	28.01%	34.54%	30.5%
Depreciation & Amortization	$22.50M	$23.81M	$23.92M
YoY Change	-5.86%	-0.48%	-5.8%
% of Gross Profit	27.41%	27.39%	24.19%
Operating Expenses	$336.8M	$267.8M	$283.3M
YoY Change	8.0%	-5.47%	-3.58%
Operating Profit	-$254.7M	-$39.01M	-$33.46M
YoY Change	6.32%	16.58%	-29.94%
Interest Expense	-$5.100M	-$5.500M	-$3.100M
YoY Change	54.55%	77.42%	-65.93%
% of Operating Profit
Other Income/Expense, Net	$9.100M	-$20.93M	-$3.880M
YoY Change	-212.35%	439.51%	-54.59%
Pretax Income	-$108.4M	-$59.94M	-$37.34M
YoY Change	6.9%	60.52%	-33.68%
Income Tax	$3.400M	$1.769M	-$11.56M
% Of Pretax Income
Net Earnings	-$112.4M	-$62.01M	-$27.66M
YoY Change	47.69%	124.22%	-23.0%
Net Earnings / Revenue	-50.08%	-27.1%	-11.07%
Basic Earnings Per Share
Diluted Earnings Per Share	-$180.5K	-$105.7K	-$49.48K
COMMON SHARES
Basic Shares Outstanding	665.6M shares	615.6M shares	559.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$85.50M	$64.70M	$43.70M
YoY Change	-11.4%	48.05%	-56.47%
Cash & Equivalents	$85.45M	$64.67M	$43.72M
Short-Term Investments
Other Short-Term Assets	$15.84M	$3.327M	$4.243M
YoY Change	311.72%	-21.59%	9.36%
Inventory	$53.43M	$50.11M	$43.38M
Prepaid Expenses
Receivables	$134.6M	$140.8M	$157.4M
Other Receivables	$23.10M	$19.90M	$24.20M
Total Short-Term Assets	$324.0M	$292.8M	$289.8M
YoY Change	1.99%	1.04%	-32.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$127.1M	$128.5M	$147.4M
YoY Change	-12.14%	-12.8%	3.47%
Goodwill	$671.9M	$695.8M	$713.6M
YoY Change	-4.04%	-2.5%	-0.27%
Intangibles
YoY Change
Long-Term Investments	$20.60M	$11.60M	$41.20M
YoY Change	-32.24%	-71.84%	36.42%
Other Assets	$6.888M	$5.528M	$9.652M
YoY Change	-4.62%	-42.73%	-74.8%
Total Long-Term Assets	$1.985B	$2.077B	$2.191B
YoY Change	-6.94%	-5.23%	-4.38%
TOTAL ASSETS
Total Short-Term Assets	$324.0M	$292.8M	$289.8M
Total Long-Term Assets	$1.985B	$2.077B	$2.191B
Total Assets	$2.309B	$2.370B	$2.481B
YoY Change	-5.79%	-4.49%	-8.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.54M	$77.30M	$65.61M
YoY Change	31.95%	17.81%	-1.39%
Accrued Expenses	$164.9M	$172.7M	$214.9M
YoY Change	-18.96%	-19.62%	21.9%
Deferred Revenue	$19.20M	$30.95M	$61.73M
YoY Change	-69.77%	-49.86%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$12.40M	$10.20M	$40.80M
YoY Change	111.93%	-75.0%	153.23%
Total Short-Term Liabilities	$249.1M	$270.1M	$317.8M
YoY Change	-13.6%	-15.01%	22.74%
LONG-TERM LIABILITIES
Long-Term Debt	$3.906M	$4.091M	$1.142M
YoY Change	-16.07%	258.23%	-1.72%
Other Long-Term Liabilities	$87.80M	$112.0M	$183.8M
YoY Change	-55.87%	-39.09%	-18.89%
Total Long-Term Liabilities	$445.4M	$457.5M	$374.5M
YoY Change	19.9%	22.14%	0.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$249.1M	$270.1M	$317.8M
Total Long-Term Liabilities	$445.4M	$457.5M	$374.5M
Total Liabilities	$694.5M	$727.6M	$692.4M
YoY Change	5.26%	5.09%	9.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.511B	-$1.399B	-$1.109B
YoY Change	26.23%	26.12%	39.96%
Common Stock	$6.704M	$6.162M	$5.604M
YoY Change	14.23%	9.96%	0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.791M	$1.791M	$1.791M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	549.9K shares	549.9K shares	549.9K shares
Shareholders Equity	$1.615B	$1.642B	$1.789B
YoY Change
Total Liabilities & Shareholders Equity	$2.309B	$2.370B	$2.481B
YoY Change	-5.79%	-4.49%	-8.85%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$112.4M	-$62.01M	-$27.66M
YoY Change	47.69%	124.22%	-23.0%
Depreciation, Depletion And Amortization	$22.50M	$23.81M	$23.92M
YoY Change	-5.86%	-0.48%	-5.8%
Cash From Operating Activities	-$46.00M	-$23.90M	-$21.90M
YoY Change	32.95%	9.13%	-41.76%
INVESTING ACTIVITIES
Capital Expenditures	-$3.800M	-$2.500M	-$12.00M
YoY Change	22.58%	-79.17%	-21.57%
Acquisitions
YoY Change
Other Investing Activities	$100.0K	$300.0K	$500.0K
YoY Change	0.0%	-40.0%	-145.45%
Cash From Investing Activities	-$3.800M	-$2.200M	-$11.50M
YoY Change	31.03%	-80.87%	-29.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	70.60M	-20.00M	-3.000M
YoY Change	-22.16%	566.67%	-113.1%
NET CHANGE
Cash From Operating Activities	-46.00M	-23.90M	-21.90M
Cash From Investing Activities	-3.800M	-2.200M	-11.50M
Cash From Financing Activities	70.60M	-20.00M	-3.000M
Net Change In Cash	20.80M	-46.10M	-36.40M
YoY Change	-60.9%	26.65%	17.42%
FREE CASH FLOW
Cash From Operating Activities	-$46.00M	-$23.90M	-$21.90M
Capital Expenditures	-$3.800M	-$2.500M	-$12.00M
Free Cash Flow	-$42.20M	-$21.40M	-$9.900M
YoY Change	33.97%	116.16%	-55.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2018Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2018Q3	opk	Number Of Derivative Lawsuits NumberOfDerivativeLawsuits	12	lawsuit
CY2019Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	0	shares
CY2019Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	0	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	586881720	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	616150952	shares
CY2018	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.01
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
CY2019Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33528
	dei	Entity Registrant Name EntityRegistrantName	OPKO Health, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-2402409
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4400 Biscayne Blvd.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Trading Symbol TradingSymbol	OPK
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	665600775	shares
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33137
	dei	City Area Code CityAreaCode	(305)
	dei	Local Phone Number LocalPhoneNumber	575-4100
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	198968000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64667000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96473000	USD
CY2019Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	457451000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	371460000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	727589000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	140765000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143907000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	50109000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	42299000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37301000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35052000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	292842000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	317731000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128519000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144674000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	564310000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	614452000	USD
CY2019Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	635000000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	635572000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	695798000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
CY2019Q3	us-gaap	Long Term Investments LongTermInvestments	11695000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	31228000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35826000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5528000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7222000	USD
CY2019Q3	us-gaap	Assets Assets	2369518000	USD
CY2018Q4	us-gaap	Assets Assets	2451072000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	77296000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	47395000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	172734000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	203513000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12921000	USD
CY2019Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2018Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	31562000	USD
CY2019Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7187000	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5851000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	270138000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	288321000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23318000	USD
CY2019Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	208695000	USD
CY2018Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	57299000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	113479000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	115193000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	111959000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	659781000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	6162000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	5869000	USD
CY2019Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3065059000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3004422000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-28774000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20131000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1398727000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1197078000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1641929000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1791291000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2369518000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2451072000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	228772000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	249815000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	677592000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	768412000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	80542000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	84071000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	264175000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	263242000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30017000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30160000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	94832000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	92258000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1109000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1193000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-78000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-12406000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16412000	USD
CY2018Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16899000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49393000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51397000	USD
CY2019Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	655000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	267783000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	283279000	USD
	us-gaap	Operating Expenses OperatingExpenses	839180000	USD
	us-gaap	Operating Expenses OperatingExpenses	849596000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39011000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-33464000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-161588000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-81184000	USD
CY2019Q3	opk	Interest Income Nonoperating InterestIncomeNonoperating	350000	USD
CY2018Q3	opk	Interest Income Nonoperating InterestIncomeNonoperating	43000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	1477000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	111000	USD
CY2019Q3	opk	Interest Expense Nonoperating InterestExpenseNonoperating	5792000	USD
CY2018Q3	opk	Interest Expense Nonoperating InterestExpenseNonoperating	2944000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	16048000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	7933000	USD
CY2019Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-21000	USD
CY2018Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-155000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3489000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15470000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-824000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20367000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9653000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20933000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3880000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-34932000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5320000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-59944000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-37344000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-196520000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-75864000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1769000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11563000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3636000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10437000	USD
CY2019Q3	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-61713000	USD
CY2018Q3	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-25781000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-200156000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-65427000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-294000	USD
CY2018Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1874000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2419000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11542000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-62007000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-27655000	USD
	us-gaap	Profit Loss ProfitLoss	-202575000	USD
	us-gaap	Profit Loss ProfitLoss	-76969000	USD
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	586351045	shares
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559786382	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	586348791	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559601097	shares
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-62007000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-27655000	USD
	us-gaap	Profit Loss ProfitLoss	-202575000	USD
	us-gaap	Profit Loss ProfitLoss	-76969000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8423000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-134000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8643000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7734000	USD
CY2019Q3	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
CY2018Q3	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	4876000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-70430000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27789000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-211218000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-89579000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1708931000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3428000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2019Q3	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	0	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-62007000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8423000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1641929000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1791291000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11007000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-3000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	50852000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-202575000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8643000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1641929000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1798540000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5077000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1455000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-34000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	856000	USD
CY2018Q3	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-27655000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-134000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	1776684000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1843623000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16591000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1174000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-76969000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7734000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1776685000	USD
	us-gaap	Profit Loss ProfitLoss	-202575000	USD
	us-gaap	Profit Loss ProfitLoss	-76969000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	71281000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	73440000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	4558000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	3559000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	506000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	155000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2419000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11542000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11007000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16591000	USD
	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	-17178000	USD
	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	14346000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-78000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-12406000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	655000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2065000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14541000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3257000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7701000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9543000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4057000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2556000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4304000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-240000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4633000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	30597000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9329000	USD
	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	147000	USD
	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	57000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-56860000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-50531000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-238000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4559000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-126485000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-74482000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1200000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1000000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1516000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	552000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1070000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	8866000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	24823000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9514000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23237000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	200293000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	55000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7762000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-3000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1173000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	99353000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	22468000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	158477000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	28435000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	28800000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	104604000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50206000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-411000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-268000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31806000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47781000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	96473000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91499000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64667000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43718000	USD
	us-gaap	Interest Paid Net InterestPaidNet	11084000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1631000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3103000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3883000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	35826000	USD
	opk	Operating Lease Liability Initial Recognition Upon Adoption OperatingLeaseLiabilityInitialRecognitionUponAdoption	36239000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	20000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	806000	USD
	opk	Numberof Sales Employees NumberofSalesEmployees	300	employee
	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</span><span style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</span></div>
	us-gaap	Inventory Write Down InventoryWriteDown	1400000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1500000	USD
CY2019Q3	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	1900000000	USD
CY2018Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2000000000.0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49400000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51400000	USD
	us-gaap	Depreciation Depreciation	21900000	USD
	us-gaap	Depreciation Depreciation	22000000.0	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of credit risk and allowance for doubtful accounts</span><span style="font-family:inherit;font-size:10pt;">. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</span></div>While we have receivables due from federal and state governmental agencies, we do not believe that such receivables represent a credit risk because the related healthcare programs are funded by federal and state governments, and payment is primarily dependent upon submitting appropriate documentation.
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1800000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1800000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	300000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	600000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11000000.0	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16600000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	24877	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	19232	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	24877	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	5645	shares
CY2018Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	208000	shares
CY2018Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	208000	shares
CY2018Q3	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	208000	shares
CY2018Q3	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	0	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	540000	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	353677	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	540000	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	186323	shares
CY2019Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	142605000	USD
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	145665000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1840000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1758000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	140765000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143907000	USD
CY2019Q3	us-gaap	Other Inventory Supplies OtherInventorySupplies	23022000	USD
CY2018Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	23264000	USD
CY2019Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	22137000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15259000	USD
CY2019Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	3239000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2473000	USD
CY2019Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	4264000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4259000	USD
CY2019Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2553000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2956000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	50109000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	42299000	USD
CY2019Q3	opk	Taxes Recoverable Current TaxesRecoverableCurrent	19705000	USD
CY2018Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	15708000	USD
CY2019Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	194000	USD
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2368000	USD
CY2019Q3	us-gaap	Supplies Supplies	8915000	USD
CY2018Q4	us-gaap	Supplies Supplies	9693000	USD
CY2019Q3	us-gaap	Prepaid Insurance PrepaidInsurance	5160000	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3436000	USD
CY2019Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3327000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3847000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37301000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35052000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	306140000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	258539000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	564310000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	614452000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30951000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	63503000	USD
CY2019Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	34138000	USD
CY2018Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	45621000	USD
CY2019Q3	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	9975000	USD
CY2018Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	10401000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2375000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2375000	USD
CY2019Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2983000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3280000	USD
CY2019Q3	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	5000000	USD
CY2018Q4	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4871000	USD
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2877000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7935000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	84435000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	65527000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	172734000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	203513000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3257000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	27566000	USD
CY2019Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	50644000	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	105198000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	22084000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	22162000	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4091000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4654000	USD
CY2019Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4325000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5620000	USD
CY2019Q3	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	27558000	USD
CY2018Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	33768000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	111959000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	198968000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-4395000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	695798000	USD
CY2019Q3	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	1448000	USD
CY2019Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	10268000	USD
CY2019Q3	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	963000	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	9129000	USD
CY2019Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	35000	USD
CY2019Q3	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	120000	USD
CY2019Q3	us-gaap	Long Term Investments LongTermInvestments	11695000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	855000	USD
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	184900000	USD
CY2019Q3	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	59900000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-42100000	USD
CY2019Q3	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	9700000	USD
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-17184000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-17184000	USD
CY2019Q3	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2019Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	122435000	USD
CY2019Q3	us-gaap	Line Of Credit LineOfCredit	56128000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	108710000	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	9129000	USD
CY2019Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	120000	USD
CY2019Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	9395000	USD
CY2019Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	24459000	USD
CY2018Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	26313000	USD
CY2018Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	27189000	USD
CY2018Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	24537000	USD
	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	1200000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	24500000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	24600000	USD
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Shares PrivatePlacementAgreementSaleOfSharesShares	26500000	shares
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Price Per Share PrivatePlacementAgreementSaleOfSharesPricePerShare	3.49
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Amount PrivatePlacementAgreementSaleOfSharesAmount	92500000	USD
CY2018Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	34000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	174000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	24500000	USD
	opk	Number Of Class Action Lawsuits NumberOfClassActionLawsuits	2	lawsuit
CY2018Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	100000	USD
CY2019Q3	us-gaap	Purchase Obligation PurchaseObligation	77500000	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	25800000	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	23400000	USD
CY2019Q3	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	25500000	USD
CY2018Q4	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	35900000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5800000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	14300000	USD
CY2019Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	34200000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	91100000	USD
CY2017Q4	opk	Proceeds From Development And License Agreement Upfront Payment ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment	6000000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-39011000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-33464000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-161588000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-81184000	USD
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23805000	USD
CY2018Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23921000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	71281000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	73440000	USD
CY2019Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-294000	USD
CY2018Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1874000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2419000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-11542000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	228772000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	249815000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	677592000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	768412000	USD
CY2019Q3	us-gaap	Assets Assets	2369518000	USD
CY2018Q4	us-gaap	Assets Assets	2451072000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	695798000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35826000	USD
CY2019Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7308000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12921000	USD
CY2019Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2983000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23318000	USD
CY2019Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4325000	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2019Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.057
CY2019Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3938000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	923000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11929000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2845000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8471000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2133000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5700000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1077000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4294000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	486000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7215000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	203000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	41547000	USD
CY2019Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7667000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5308000	USD
CY2019Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	360000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	36239000	USD
CY2019Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	7307000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	15300000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2300000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	2600000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	15664000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	306000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2165000	USD
	opk	Payments For Leases PaymentsForLeases	18135000	USD

Files In Submission

Name	View Source	Status
0000944809-19-000080-index-headers.html	Edgar Link	pending
0000944809-19-000080-index.html	Edgar Link	pending
0000944809-19-000080.txt	Edgar Link	pending
0000944809-19-000080-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nai150734072612jpmcbrl.htm	Edgar Link	pending
opk-20190930.xsd	Edgar Link	pending
opk-20190930_cal.xml	Edgar Link	unprocessable
opk-20190930_def.xml	Edgar Link	unprocessable
opk-20190930_lab.xml	Edgar Link	unprocessable
opk-20190930_pre.xml	Edgar Link	unprocessable
opk-9302019x10q.htm	Edgar Link	pending
opk-9302019x10q_htm.xml	Edgar Link	completed
opk-9302019xex311.htm	Edgar Link	pending
opk-9302019xex312.htm	Edgar Link	pending
opk-9302019xex321.htm	Edgar Link	pending
opk-9302019xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2019 Q4 Form 10-Q Financial Statement

#000094480919000080 Filed on November 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2019 Q4 Form 10-Q Financial Statement

#000094480919000080 Filed on November 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk